Buprenorphine Tablet
Product Images NDC 71335-0950

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Buprenorphine (NDC 71335-0950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Buprenorphine 01)

Chemical structure diagram of buprenorphine hydrochloride, showing the molecular arrangement with labeled atoms and bonds, including hydroxyl, methoxy groups, and the cyclopropylmethyl substituent on the nitrogen.*

FDA Label Image

Image (Buprenorphine 02)

An instructional illustration showing a person tilting back their lower lip to place a sublingual tablet beneath it. The image highlights the correct placement area for the tablet inside the mouth for sublingual administration.*

FDA Label Image

Label Image (Lbl713350950)

Label for Buprenorphine SL 2 mg (CIII) sublingual tablets, packaged by Bryant Ranch Prepack, Burbank, CA. The label shows comparison to Subutex SL 2 mg tablets by Purdue Pharma. It mentions storage at room temperature (20-25°C), a warning about drowsiness, and keeping drugs out of reach of children. The pack size is 60 tablets, with NDC 71335-0950-1.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.